RCEL
Avita Medical Ltd
13.20$
-0.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -65.8% | -76.5% | -187.9% | -84.1% | -36.9% | -43.9% | -55.7% | -55.5% | -30.6% | -30.9% | -52.3% | -16.1% | -32.0% | |
| 1.2% | 1.3% | 1.8% | 1.3% | 1.6% | 2.2% | 2.8% | 3.0% | 3.4% | 2.2% | 3.3% | 2.8% | 2.9% | |
| 17.8% | 15.3% | 23.3% | 26.5% | 20.9% | 15.2% | 14.6% | 14.5% | 16.3% | 7.8% | 5.7% | 9.2% | 9.6% | |
| -21.3% | 0.0% | -56.2% | -0.3% | 12.1% | -4.1% | 1.3% | -9.7% | 5.6% | 22.9% | -11.6% | 5.5% | 5.2% | |
| 3.8% | 2.3% | 11.1% | 17.5% | 19.5% | 8.9% | 1.3% | 2.8% | 5.6% | 9.7% | 0.1% | 0.5% | 3.7% | |
| 159.5% | -403.7% | 135.7% | 81.8% | 37.8% | 13.4% | 58.2% | 38.1% | -31.3% | 0.1% | 10.6% | 17.9% | 0.8% | |
| – | – | – | – | – | – | 0.0% | 0.0% | – | – | 31.7% | 0.0% | – | |
| 4.4% | 277.8% | 5.7% | 5.6% | 5.2% | 5.5% | 2.0% | 3.0% | 80.7% | 1.4% | 31.7% | 2.0% | 27.2% | |
| 98.0% | -202.4% | -46.5% | 3.3% | 6.1% | -24.9% | 4.4% | -14.4% | 18.8% | -29.4% | -10.0% | 3.8% | -4.1% | |
| -69.5% | -78.9% | -199.0% | -101.6% | -56.4% | -52.8% | -56.9% | -58.4% | -36.2% | -21.1% | -52.4% | -16.6% | -31.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.